While surgery, radiotherapy and chemotherapy are able to cure many cancers, new approaches are required to improve radical curative therapy. A possible route is to utilize the latest achievements made in research on the immunology and genetics of cancer. Cancer immunotherapy, or the manipulation of the naturally occurring oncolytic immune reaction, is based on the observation that both in animals and humans neoplastic cell antigens stimulate the onset of specific humoral and cellular antibodies. Tarro et al. demonstrated that when TLP is extracted from a tumor, purified in the laboratory, and reintroduced into the patientâs body, it boosts the immune systemâs cancer responsive capabilities. Vs Tarro G, Tumor Liberated Protein (TLP) from lung cancer and perspectives for immunotherapy. Drug Designing Open Access strives to release issues quarterly and is adamant to publish new findings related to the field of in-silico drug designing, high-throughput screening, drug targets, and structure-activity relationships.
Last date updated on January, 2021